How does a pharmacy weather a flood, with a community relying on ongoing care? Bridget Totterman and Rachel Hetherington shared their personal experiences and lessons at PSA25 When major flooding …

The opposition health spokeswoman reaffirmed her commitment to holding the government to account on implementing the full scope review at PSA25 Policymakers must ensure “every single health professional is operating …

Community pharmacy in the US is facing new competition from digital entrants such as Amazon, while market uncertainty is affecting vaccine uptake, the ASX-listed company says Pharmacy software company MedAdvisor …

Post-merger Sigma says it’s positioning the Amcal brand for future growth and category expansion by “leveraging the sales and marketing expertise of the Chemist Warehouse team” Sigma Healthcare says it’s …

How does a pharmacist’s own experiences with mental health affect how they screen and respond to at-risk patients? Researchers in Western Australia investigated Pharmacists’ lived experience with suicide affects how …

The pharmacy technology company’s shareholders will vote on plans to link part of the CEO’s benefits to long-term market performance   MedAdvisor investors will look at giving the company’s CEO …

In the aftermath of selling its local business, pharmacy software company MedAdvisor is still reviewing its strategic options, which may include offloading its US arm MedAdvisor Solutions has appointed a …

Almost one-in-five Australians with chronic conditions have foregone medication or care due to cost, according to a landmark international survey Price and distance have emerged as two of the main …

Mario Verrocchi has made his debut on the Australian Financial Review’s Rich Bosses list, which gives the market a glimpse of his enormous post-merger shareholder wealth Chemist Warehouse co-founder Mario …

The pharmacy ordering platform says the renewal will help it to hit growth objectives Pharmx has locked in a 12-month extension to its supplier arrangement with the National Diabetes Services …

Estimates suggest a 200% tariff on pharmaceuticals could strip billions from the Australian economy, with authorities seeking clarity on what it would mean for local markets US President Donald Trump …

A powerful US pharma lobby group has come after Australia’s PBS, claiming it sets drug prices too low – and should pay the price, a report shows The Pharmaceutical Research …